PMDA drug package insert
ロサルタンK錠25mg「DSEP」
PMDA Prescription drug · 第一三共エスファ株式会社 · package insert Sep 9, 2025
Key facts
| Brand names | ロサルタンK錠25mg「DSEP」, ロサルタンK錠50mg「DSEP」, ロサルタンK錠100mg「DSEP」 |
|---|---|
| Nonproprietary names | ロサルタンカリウム |
| Companies | 製造販売元／第一三共エスファ株式会社, 販売提携／第一三共株式会社 |
| Product type | Prescription drug |
| Therapeutic category | A–Ⅱアンタゴニスト |
| Therapeutic category codes | 872149 |
| YJ codes | 2149039F1040, 2149039F2046, 2149039F3034 |
| Approval numbers | 22400AMX00408, 22400AMX00409, 22400AMX00410 |
| Package insert edition | 第3版 |
| Package insert date | Sep 9, 2025 |
| PMDA document key | 430773_2149039F1040_1 |
| PMDA company code | 430773 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: